Form 8-K

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): February 12, 2007

CAREMARK RX, INC.

(Exact Name of Registrant

as Specified in Charter)

 

 

1-14200    Delaware    63-1151076
(Commission File Number)    (State or Other Jurisdiction of Incorporation)    (IRS Employer Identification No.)

211 Commerce Street, Suite 800,

Nashville, Tennessee

       37201
(Address of Principal Executive Offices)       (Zip Code)

Registrant’s telephone number, including area code: (615) 743-6600

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Section 8 – Other Events

Item 8.01 Other Events

Attached hereto as Exhibit 99.1 and incorporated herein by reference is a press release issued by Caremark Rx, Inc. (“Caremark” or the “Registrant”) on February 12, 2007.

Item 9.01 Financial Statements and Exhibits

 

(c) Exhibits

 

Exhibit No.     
99.1    Press release dated February 12, 2007.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      CAREMARK RX, INC.
Date:   February 12, 2007     By:   /s/ Peter J. Clemens IV
        Name: Peter J. Clemens IV
       

Title:   Executive Vice President

            and Chief Financial Officer